The present invention includes novel RAD52 inhibitors for preventing or treating cancers in a subject in need thereof. The present invention further includes a method of preventing or treating cancers in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of the invention. In certain embodiments, the subject is further administered at least one additional therapeutic agent.
本发明包括用于预防或治疗患有癌症的受试者的新型RAD52
抑制剂。本发明还包括一种预防或治疗患有癌症的受试者的方法,该方法包括向受试者投与本发明化合物的有效量。在某些实施方式中,受试者还会投与至少一种其他治疗药物。